Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants (Q30419512)

11 August 2017

Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants (English)

1 reference

11 August 2017

1 reference

ChEBI release 2020-05-28

William Sivitz

10

0 references

John Buse

object named as

John Buse

4

0 references

Uma Nayak

3

object named as

Uma Nayak

1 reference

11 August 2017

9

Santica Marcovina

1 reference

11 August 2017

11

Joann Sperl-Hillen

1 reference

11 August 2017

Josyf C Mychaleckyj

1

1 reference

11 August 2017

Timothy Craven

2

1 reference

11 August 2017

John R Crouse

5

1 reference

11 August 2017

Marshall Elam

6

1 reference

11 August 2017

Kent Kirchner

7

1 reference

11 August 2017

Daniel Lorber

8

1 reference

11 August 2017

Denise E Bonds

12

1 reference

11 August 2017

Henry N Ginsberg

13

1 reference

11 August 2017

language of work or name

English

0 references

publication date

19 March 2012

1 reference

11 August 2017

1 reference

11 August 2017

35

1 reference

11 August 2017

5

1 reference

11 August 2017

1008-1014

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

11 August 2017

start time

1 September 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Effects of combination lipid therapy in type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329840

Effects of long-term fenofibrate treatment on markers of renal function in type 2 diabetes: the FIELD Helsinki substudy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329840

A new equation to estimate glomerular filtration rate

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329840

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329840

Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329840

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329840

Deterioration in renal function associated with fibrate therapy.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329840

Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329840

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329840

Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329840

Effect of fenofibrate on kidney function: a 6-week randomized crossover trial in healthy people

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329840

Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329840

Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329840

Effect of fenofibrate-mediated increase in plasma homocysteine on the progression of coronary artery disease in type 2 diabetes mellitus

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329840

Effects of fenofibrate and gemfibrozil on plasma homocysteine

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329840

The long-term effects of the lipid-lowering agent fenofibrate in hyperlipidemic heart transplant recipients.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3329840

Fenofibrate increases creatininemia by increasing metabolic production of creatinine

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22432114

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Fenofibrate therapy of hyperlipoproteinaemia a dose—response study and a comparison with clofibrate

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22432114

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Fenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22432114

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2337/DC11-1811

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22432114

1 reference